Psoriasis and hypertension: A case-control study

Acta Dermato-Venereologica

Volumn 90, Issue 1, 2010, Pages 23-26

  Cohen, Arnon D ^a   Weitzman, Dahlia ^a   Dreiher, Jacob ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Chronic co morbidity; Hypertension; Metabolic syndrome; Psoriasis

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG USE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OBESITY; PATIENT ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; SCREENING TEST; SMOKING;

ADULT; AGED; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; COMORBIDITY; DATA MINING; FEMALE; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; HYPERTENSION; ISRAEL; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; PSORIASIS; RISK ASSESSMENT; RISK FACTORS;

EID: 76349121073     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0741     Document Type: Article

References (33)

1. Naldi L, Chatenoud L, Belloni A, Peserico A, Balato N, Virgili AR, et al. Medical history, drug exposure and the risk of psoriasis. Evidence from an Italian case-control study. Dermatology 2008; 216: 125-130.
2. Naldi L, Chatenoud L, Linder D, Belloni Fortina A, Peserico A, Virgili AR, et al. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J Invest Dermatol 2005; 125: 61-67.
3. Naldi L, Peli L, Parazzini F. Association of early-stage psoriasis with smoking and male alcohol consumption: evidence from an Italian case-control study. Arch Dermatol 1999; 135: 1479-1484.
4. Naldi L, Peli L, Parazzini F, Carrell CF, Psoriasis Study Group of the Italian Group for Epidemiological Research in Dermatology. Family history of psoriasis, stressful life events, and recent infectious disease are risk factors for a first episode of acute guttate psoriasis: results of a case-control study. J Am Acad Dermatol 2001; 44: 433-438.
5. Malerba M, Gisondi P, Radaeli A, Sala R, Calzavara Pinton PG, et al. Plasma homocysteine and folate levels in patients with chronic plaque psoriasis. Br J Dermatol 2006; 155: 1165-1169.
6. Cohen AD, Gilutz H, Henkin Y, Zahger D, Shapiro J, Bonneh DY, et al. Psoriasis and the metabolic syndrome. Acta Derm Venereol 2007; 87: 506-509.
7. Cohen AD, Sherf M, Vidavsky L, Vardy DA, Shapiro J, Meyerovitch J. Association between psoriasis and the metabolic syndrome. A cross-sectional study. Dermatology 2008; 216: 152-155.
8. Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA 2006; 296: 1735-1741.
9. Gisondi P, Tessari G, Conti A, Piaserico S, Schianchi S, Peserico A. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol 2007; 157: 68-73.
10. Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol 1995; 32: 982-986.
11. Huerta C, Rivero E, Rodriguez LA. Incidence and risk factors for psoriasis in the general population. Arch Dermatol 2007; 143: 1559-1565.
12. Inerot A, Enerback C, Enlund F, Martinsson T, Samuelsson L, Wahlström J. et al. Collecting a set of psoriasis family material through a patient organisation; clinical characterisation and presence of additional disorders. BMC Dermatol 2005; 5: 10.
13. Kremers HM, McEvoy MT, Dann FJ, Gabriel SE. Heart disease in psoriasis. J Am Acad Dermatol 2007; 57: 347-354.
14. Lindegard B. Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes. Dermatologica 1986; 172: 298-304.
15. Lindegard B. Mortality and causes of death among psoriatics. Dermatologica 1989; 179: 91-92.
16. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006; 55: 829-835.
17. Pearce DJ, Morrison AE, Higgins KB, Crane MM, Balkrishnan R, FleischerAB, et al. The comorbid state of psoriasis patients in a university dermatology practice. J Dermatolog Treat 2005; 16: 319-323.
18. Shapiro J, Cohen AD, David M, Hodak E, Chodik G, Viner A, et al. The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study. J Am Acad Dermatol 2007; 56: 629-634.
19. Sommer DM, Jenisch S, Suchan M, Christophers E, Weichental M. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 2006; 298: 321-328.
20. Alberti KG, Zimmet P. The metabolic syndrome: time to reflect. Curr Diab Rep 2006; 6: 259-261.
21. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome - a new worldwide definition. Lancet 2005; 366: 1059-1062.
22. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006; 23: 469-480.
23. Timar O, Sestier F, Levy E. Metabolic syndrome X: a review. Can J Cardiol 2000; 16: 779-789.
24. Zambon A, Pauletto P, Crepaldi G. Review article: the metabolic syndrome - a chronic cardiovascular inflammatory condition. Aliment Pharmacol Ther 2005; 22 Suppl 2: 20-23.
25. Bowcock AM. Understanding the pathogenesis of psoriasis, psoriatic arthritis, and autoimmunity via a fusion of molecular genetics and immunology. Immunol Res 2005; 32: 45-56.
26. Rennert G, Peterburg Y. Prevalence of selected chronic diseases in Israel. Isr Med Assoc J 2001; 3: 404-408.
27. Phillips MI, Kagiyama S. Angiotensin II as a proinflammatory mediator. Curr Opin Investig Drugs 2002; 3: 569-577.
28. Huskic J, Alendar F. Tissue angiotensin-converting enzyme in patients with various clinical forms of psoriasis. Bosn J Basic Med Sci 2007; 7: 103-106.
29. Ryder KW, Epinette WW, Jay SJ, Ransburg Rc, Glick MR. Serum angiotensin converting enzyme activity in patients with psoriasis. Clin Chim Acta 1985; 153: 143-146.
30. Ena P, Madeddu P, Glorioso N, Cerimele D, Rappelli A. High prevalence of cardiovascular diseases and enhanced activity of the renin-angiotensin system in psoriatic patients. Acta Cardiol 1985; 40: 199-205.
31. Bonifati C, Mussi A, Carducci M, D'auria L, Ameglio F. Endothelin-1 levels are increased in sera and lesional skin extracts of psoriatic patients and correlate with disease severity. Acta Derm Venereol 1998; 78: 22-26.
32. Sowers JR. Hypertension, angiotensin II, and oxidative stress. N Engl J Med 2002; 346: 1999-2001.
33. Berkson J. Limitations of the application of four-fold table analysis to hospital data. Biometrics 1946; 2: 47-53.